• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CHS USA Inc. Acquires Medical Imaging Solutions International

Share:

October 11, 2022

CHS USA Inc., a company of Canadian Hospital Specialties Limited (CHS), completed the acquisition of Medical Imaging Solutions International. (“MISI”), effective September 16th, 2022. This acquisition will further increase CHS’ presence in the United States diagnostic imaging market. MISI and CHS are known in the healthcare industry for high quality and reliable products.

“This acquisition is a great fit for CHS because we share similar qualities, values, capabilities and offerings. The MISI acquisition is a great platform for US expansion in the diagnostic imaging market,” states Mike Canzoneri, President and CEO of CHS.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Healthcare Metadata Management: 3 Critical Capabilities to Creating A Unified, Automated ApproachHealthcare Metadata Management: 3 Critical Capabilities to Creating A Unified, Automated Approach
  • MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences SharesMediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares
  • BioNTech Buys Kite TCR Cell Therapy Plant to Boost US TrialsBioNTech Buys Kite TCR Cell Therapy Plant to Boost US Trials
  • Illumina’s deal for PacBio raises competition concerns, CMA saysIllumina’s deal for PacBio raises competition concerns, CMA says
  • UCB Flexes M&A Muscles to Bolster its Gene Therapy CapabilitiesUCB Flexes M&A Muscles to Bolster its Gene Therapy Capabilities
  • NorthStar Anesthesia Completes Acquisition of Surgery Partners Anesthesia Services BusinessNorthStar Anesthesia Completes Acquisition of Surgery Partners Anesthesia Services Business
  • Babylon Study Finds New AI with ‘imagination’ is More Effective Than GPS at Medical DiagnosisBabylon Study Finds New AI with ‘imagination’ is More Effective Than GPS at Medical Diagnosis
  • Clinical Trials Software Market: Distribution By Type of Deployment, Type of Delivery, Features of Software and Geographical Regions, Industry Trends and Global Forecasts, 2022-2035Clinical Trials Software Market: Distribution By Type of Deployment, Type of Delivery, Features of Software and Geographical Regions, Industry Trends and Global Forecasts, 2022-2035

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications